EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts

Brandon J Vogt, Megan Chavez, Nicole E Félix Vélez, Rayyan M Gorashi, Ryan R Reeves, Brian A Aguado

Cell Reports · 2026-07 · 45 (7) · 117678

DOI: 10.1016/j.celrep.2026.117678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Brandon J Vogt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 2, Aortic Valve Stenosis, Myofibroblasts, Drug Resistance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, The Chan Zuckerberg Initiative, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor Binding Protein 2Aortic Valve StenosisMyofibroblastsDrug ResistanceAortic ValveFemaleHumansAnimalsMaleSignal Transduction

Stichwörter der Autor:innen

CP: cell biologyaortic valve stenosisbiomarkerevogliptinfibroblasthydrogelsigf1igfbp2proteomicsserumsex differences

Substanzen

Insulin-Like Growth Factor Binding Protein 2IGFBP2 protein, human

Autor:innen und Institutionen

  • Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
  • Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, CA, USA.
  • Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA; Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA; Program in Materials Science and Engineering, Uni…

Förderung

  • NHLBI NIH HHS
  • The Chan Zuckerberg Initiative
  • National Heart Lung and Blood Institute
  • American Heart Association Inc
  • National Science Foundation

Zitieren

APA

Vogt, B. J., Chavez, M., Félix Vélez, N. E., Gorashi, R. M., Reeves, R. R., & Aguado, B. A. (2026). Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts. Cell Reports, 45(7), 117678. https://doi.org/10.1016/j.celrep.2026.117678

Vancouver

Vogt BJ, Chavez M, Félix Vélez NE, Gorashi RM, Reeves RR, Aguado BA. Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts. Cell Reports. 2026;45(7):117678. doi:10.1016/j.celrep.2026.117678

BibTeX
@article{Vogt2026,
  author = {Vogt, Brandon J and Chavez, Megan and Félix Vélez, Nicole E and Gorashi, Rayyan M and Reeves, Ryan R and Aguado, Brian A},
  title = {Aortic valve stenosis serum IGFBP2 mediates female-specific Evogliptin resistance in valve myofibroblasts},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117678},
  doi = {10.1016/j.celrep.2026.117678}
}
Kostenlos starten →